The prospects for antisense therapy

The use of short spans of nucleic acid--DNA or RNA--to disrupt the expression of disease-related genetic code is an idea potentially applicable to a vast number of illnesses, including most neoplasms. On several fronts, including hematologic malignancies, the concept has reached clinical trials--where appreciation of the in vivo hurdles is leading to new approaches for delivery of this new magic bullet.